YOON&YANG
Jiwook Kim Partner
김지욱 변호사.jpg
  • TEL 82 2 6182 8307
  • FAX 82 2 6003 7806
  • E-MAIL
Jiwook Kim is a partner at Yoon & Yang LLC, and his main practice areas include mergers and acquisitions, corporate law, foreign investment, and overseas investment.
In particular, Mr. Kim is specialized in advising on various types of M&As and corporate restructuring, as well as international transactions including both inbound and outbound investments.
Before joining the firm, Mr. Kim worked as an in-house counsel of NHN Co., Ltd. and based on such experience, he provides optimal legal services on IT and privacy issues. He was also a Personal Data Law Advisor of the Korea Communications Commission in 2015. He has recently been providing consultations on legal issues regarding initial coin offering (ICO) and cryptocurrencies.

Experience

  • 2012-present Yoon & Yang LLC
  • 2023-present Adjunct Professor, Korea University School of Law
  • 2022-present Member, Overseas Investment Business Deliberation Committee, Korea Expressway Corporation
  • 2016 Personal Data Law Advisor, Korea Communications Commission
  • 2009-11 In-house Attorney, NAVER Corporation

Education

  • 2019 Korea University School of Law (LL.D. course completion)
  • 2012 University of Southern California Gould School of Law, LL.M.
  • 2009 Judicial Research and Training Institute
  • 2007 Korea University College of Law, LL.B.

Representative Matters

[Sale and Purchase of Shares]

  • Advised on acquisition of convertible preferred shares in Skin N Skin by Samho Green Invest
  • Advised on acquisition of shares and management rights of Nassau Golf by TaylorMade Korea
  • Advised on acquisition of shares and management rights of Natural Life Nutrition Inc. and Sunlife Nutrition Inc. (Canada) by Eone Diagnomics
  • Advised on acquisition of shares of KOC Solution (foreign invested enterprise in Korea) by Mitsui Chemical Inc.
  • Advised on issuance of convertible shares by Storywiz (subsidiary of KT)
  • Advised on acquisition of shares of SKF Marine Korea by Boll & Kirch Filterbau GmbH (Germany)
  • Advised on acquisition of shares of Macquarie Investment Management by Feynman Invest
  • Advised on sale and purchase of shares of BA Entertainment and Perfect Storm Film by JTBC Studio
  • Advised on acquisition of redeemable convertible preferred shares of i2max by Salesforce LLC (US)
  • Advised on acquisition of shares of Biod FD&C Co., Ltd. by Givaudan S.A. (Switzerland)
  • Advised on acquisition of shares of Pangen Co., Ltd. by Chemical Company of Malaysia Berhad (Malaysia)
  • Advised on acquisition of shares of Erae Automotive Systems Co., Ltd. by HT-SAAE (Chinese state-run company)
  • Advised on acquisition of shares of Foodist Food Co., Ltd. (Shanghai) by Hyundai Green Food
  • Advised on acquisition of PT Valbury Sekuritas Indonesia (Indonesian securities company) by KB Securities
  • Advised on the sale of shares in HD Investment Association by the largest shareholder of Wooridul Pharmaceutical
  • Advised on acquisition of shares in LIS (KOSDAQ-listed Korean company) by Jiangsu Yawei Technology Investment
  • Advised on acquisition of shares of Wisdom House Medida Group by Comico Corp. (Japan)
  • Advised on acquisition of shares of SK B&T PTE Ltd. (Singapore) by Shinyoung Securities
  • Advised on acquisition of shares of Lyanature Co. by LG Household & Healthcare Co.
  • Advised on acquisition of shares of QDillion (Joonggonara) Co. by NHN Co.
  • Advised on acquisition of shares of Pop Funding Co. by NHN Co.
  • Advised on acquisition of shares of TMON Plus Co. by NHN Co.
  • Advised on acquisition of shares of PNP Secure by NHN co.


[Transfer of Business/Assets and Merger]

  • Advised on transfer of the non-surgical business of Lumenis Korea
  • Advised on merger of Hanwha Life Lab (subsidiary of Hanwha Life) and Hanwha Financial Asset
  • Advised on merger of Hanwha Life Lab and Ains Financial Service
  • Advised on transfer of the Kids’ Schole business by ST Unitas
  • Advised on transfer of the X-ray business of Carestream Health Korea by JV Medical
  • Advised on transfer of the pigment and additive business by Clariant Plastics & Coatings


[Due Diligence in Relation to Capital Increase of Listed Companies]

  • Advised on due diligence of Korean Air in relation to capital increase with consideration (2017, 2020, 2021)
  • Advised on due diligence of Jeju Air in relation to capital increase with consideration
  • Advised on due diligence of Medytox in relation to capital increase with consideration
  • Advised on due diligence in relation to Hyundai Merchant Marine Co., Ltd.’s public offering of non-guaranteed bonds with warrant


[Others]

  • Advised on Hana Alternative Asset Management’s investment in real estate in Dallas, United States
  • Advised on joint venture between Swissport International Ltd. (Switzerland) and Air Innovation Korea
  • Handled the joint audit of KAPES, Inc. (joint venture of GE and KEPCO)
  • Advised on credit facility and collateralization of domestic companies by PNC Bank and Citi Bank (US)
  • Advised on creation of sponsor guarantee in relation to provision of credit facilities to a domestic company by Brazilian National Development Bank
  • Advised on collaterals and guaranteed transactions of loan facilities of Eland World’s overseas subsidiaries (Lochcarron, Mandarina Duck, Coccinelle)
  • Advised Penta Security Systems and Firma Innovation Group regarding domestic and overseas ICO projects

Publications

  • Korea Chapter, Foreign Direct Investment Regimes, International Comparative Legal Guides, Global Legal Group (Co-author, 2023-2024)

Insights